JNJ-38893777
JNJ-38893777 is an orally active and highly selective transient receptor potential vanilloid type 1 (TRPV1) channel antagonist. JNJ-38893777 inhibits neuronal hyperactivation and reduces inflammatory hyperalgesia. JNJ-38893777 is promising for research of migraine headaches, neuropathic and inflammatory pain[1].
Product Specifications
CAS Number
951135-00-5
UNSPSC
12352005
Target
TRP Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
FC(C1=CC=CN=C1N2CCC3=NC(N4CCCCC4)=NC(NC5=CC=C(C(F)(F)F)C=C5)=C3CC2)(F)F
Molecular Formula
C26H26F6N6
Molecular Weight
536.52
References & Citations
[1]Manitpisitkul P, et al. Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men. Clin Drug Investig. 2015 Jun;35 (6) :353-63.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042431-500 1x 500 µL
BAP1 (BRCA1 Associated Protein 1) (BAP1/2431), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
